Clinical Trials Browser

Phase 2 × Unknown × Liver Diseases × Clear all

NCT05662813 2022-12-23

Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy

Phase 2 Unknown

55 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Digestive System Diseases, Liver Diseases

NCT01423708 2012-07-18

EPOCAL

Phase 2 Unknown

117 enrolled

Gastrointestinal

Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Phase 2 Unknown

40 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Unknown

32 enrolled

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases